Novel Formulations of the Antiviral Drug Favipiravir: Improving Permeability and Tabletability
Xinyuan Wang,Lei Wang,Changlin Yao,Guanying Xie,Shuhong Song,Huimin Li,Yaqian Qu,Xutang Tao
DOI: https://doi.org/10.1021/acs.cgd.1c00150
2021-06-01
Abstract:Recently, favipiravir, as a broad-spectrum antiviral drug, has gain more attention because it might be a candidate to remedy the coronavirus disease 2019 (COVID-19). To improve its poor permeability and tabletability, four multicomponent crystals of favipiravir (FPV) were prepared by a slow evaporation or liquid-assisted grinding method, including three cocrystals (FPV-theophylline, 1:1; FPV-saccharin, 1:1; FPV-5-fluorouracil, 1:1) and one salt (FPV-piperazine, 2:1). All of the crystal structures were solved by single-crystal X-ray diffraction. Interestingly, FPV-theophylline has a crystal structure similar to that of FPV, leading to similar properties, such as solubility, permeability, and tabletability. Except for FPV-theophylline, all of the other multicomponent crystals exhibit an enhanced permeability and tabletability. Our studies provide a new insight in overcoming the shortcomings of the important antiviral drug FPV.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.cgd.1c00150?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.cgd.1c00150</a>.Preparation of PAMPA, DSC thermograms of FPV and FPV-TP, cavity structure of FPV-PP, 3D structures of FPV and FPV-TP, crystal structures of the FPV-PP salt and the FPV-5FU and FPV-SAC cocrystals, chromatographic parameters, thermal data of FPV and its salt and cocrystals, experimental conditions for studying compressibility, and flow properties and compressibility parameters (<a class="ext-link" href="/doi/suppl/10.1021/acs.cgd.1c00150/suppl_file/cg1c00150_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
chemistry, multidisciplinary,materials science,crystallography